158 related articles for article (PubMed ID: 24650640)
21. Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
Shallal HM; Russu WA
Eur J Med Chem; 2011 Jun; 46(6):2043-57. PubMed ID: 21429632
[TBL] [Abstract][Full Text] [Related]
22. Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: optimization of the aniline.
Ducray R; Jones CD; Jung FH; Simpson I; Curwen J; Pass M
Bioorg Med Chem Lett; 2011 Aug; 21(16):4702-4. PubMed ID: 21764307
[TBL] [Abstract][Full Text] [Related]
23. Syntheses of novel β-carboline derivatives and the activities against five tumor-cell lines.
Bai B; Li XY; Liu L; Li Y; Zhu HJ
Bioorg Med Chem Lett; 2014 Jan; 24(1):96-8. PubMed ID: 24345445
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of novel tetrahydro-β-carboline derivatives as antitumor growth and metastasis agents through inhibiting the transforming growth factor-β signaling pathway.
Zheng C; Fang Y; Tong W; Li G; Wu H; Zhou W; Lin Q; Yang F; Yang Z; Wang P; Peng Y; Pang X; Yi Z; Luo J; Liu M; Chen Y
J Med Chem; 2014 Feb; 57(3):600-12. PubMed ID: 24417479
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and cytotoxic activity of novel quinazolino-beta-carboline-5-one derivatives.
Baruah B; Dasu K; Vaitilingam B; Mamnoor P; Venkata PP; Rajagopal S; Yeleswarapu KR
Bioorg Med Chem; 2004 May; 12(9):1991-4. PubMed ID: 15080902
[TBL] [Abstract][Full Text] [Related]
26. [Synthesis and antitumor activity of novel tetrahydro-beta-carboline derivatives as KSP inhibitors].
Ruan XQ; Chen M; Wu WT; You QD
Yao Xue Xue Bao; 2013 Jul; 48(7):1119-23. PubMed ID: 24133978
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines.
Shi B; Cao R; Fan W; Guo L; Ma Q; Chen X; Zhang G; Qiu L; Song H
Eur J Med Chem; 2013 Feb; 60():10-22. PubMed ID: 23279863
[TBL] [Abstract][Full Text] [Related]
28. Discovery of 4-anilino-N-methylthieno[3,2-d]pyrimidines and 4-anilino-N-methylthieno[2,3-d]pyrimidines as potent apoptosis inducers.
Kemnitzer W; Sirisoma N; May C; Tseng B; Drewe J; Cai SX
Bioorg Med Chem Lett; 2009 Jul; 19(13):3536-40. PubMed ID: 19464890
[TBL] [Abstract][Full Text] [Related]
29. 4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2).
Olsson H; Sjö P; Ersoy O; Kristoffersson A; Larsson J; Nordén B
Bioorg Med Chem Lett; 2010 Aug; 20(16):4738-40. PubMed ID: 20643547
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of new tryptamine and tetrahydro-beta-carboline-based selective inhibitors of CDK4.
Jenkins PR; Wilson J; Emmerson D; Garcia MD; Smith MR; Gray SJ; Britton RG; Mahale S; Chaudhuri B
Bioorg Med Chem; 2008 Aug; 16(16):7728-39. PubMed ID: 18650093
[TBL] [Abstract][Full Text] [Related]
31. 2-Anilino-4-(benzimidazol-2-yl)pyrimidines--a multikinase inhibitor scaffold with antiproliferative activity toward cancer cell lines.
Determann R; Dreher J; Baumann K; Preu L; Jones PG; Totzke F; Schächtele C; Kubbutat MH; Kunick C
Eur J Med Chem; 2012 Jul; 53():254-63. PubMed ID: 22560627
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumor activity of β-carboline 3-(substituted-carbohydrazide) derivatives.
Barbosa VA; Formagio AS; Savariz FC; Foglio MA; Spindola HM; de Carvalho JE; Meyer E; Sarragiotto MH
Bioorg Med Chem; 2011 Nov; 19(21):6400-8. PubMed ID: 21944971
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and structure--activity relationships of N²-alkylated quaternary β-carbolines as novel antitumor agents.
Zhang G; Cao R; Guo L; Ma Q; Fan W; Chen X; Li J; Shao G; Qiu L; Ren Z
Eur J Med Chem; 2013 Jul; 65():21-31. PubMed ID: 23688697
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of novel beta-carbolines with efficient DNA-binding capacity and potent cytotoxicity.
Chen Z; Cao R; Shi B; Yi W; Yu L; Song H; Ren Z; Peng W
Bioorg Med Chem Lett; 2010 Jul; 20(13):3876-9. PubMed ID: 20627721
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.
Zhao M; Bi L; Wang W; Wang C; Baudy-Floc'h M; Ju J; Peng S
Bioorg Med Chem; 2006 Oct; 14(20):6998-7010. PubMed ID: 16806943
[TBL] [Abstract][Full Text] [Related]
36. [The design, synthesis and anticancer activity of 4-heteroarylamino-3-cyanoquinolines as dual inhibitors of c-Src and iNOS].
Cao X; You QD; Li ZY; Guo QL; Yang Y; Shang J; Yan M; Chen JW; Chen ML
Yao Xue Xue Bao; 2009 Mar; 44(3):288-95. PubMed ID: 19449526
[TBL] [Abstract][Full Text] [Related]
37. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.
Ghosh S; Zheng Y; Jun X; Mahajan S; Mao C; Sudbeck EA; Uckun FM
Clin Cancer Res; 1999 Dec; 5(12):4264-72. PubMed ID: 10632369
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of substituted 3-anilino-quinolin-2(1H)-ones as PDK1 inhibitors.
O'Brien NJ; Brzozowski M; Wilson DJ; Deady LW; Abbott BM
Bioorg Med Chem; 2014 Jul; 22(14):3781-90. PubMed ID: 24856302
[TBL] [Abstract][Full Text] [Related]
39. Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity.
Xu YY; Li SN; Yu GJ; Hu QH; Li HQ
Bioorg Med Chem; 2013 Oct; 21(19):6084-91. PubMed ID: 23962660
[TBL] [Abstract][Full Text] [Related]
40. [Synthesis and antitumor activities of 1-(4-chlorophenyl)-beta-carboline derivatives].
Ma Q; Guo L; Sun J; Fan WX
Yao Xue Xue Bao; 2013 Jan; 48(1):77-82. PubMed ID: 23600145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]